Physician profile
Giovanni B Ramundo
NPI 1679671481
$700.13
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $33.33 · 2021: $247 · 2022: $45.57 · 2023: $38.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $251.38 | 2019-2023 | Eterna |
| Nevro Corp. | $227.59 | 2019-2021 | |
| Boston Scientific Corporation | $109.96 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Vertiflex, INC. | $19.17 | 2019 | |
| Abbvie INC. | $14.98 | 2022 | |
| Medtronic USA, INC. | $14.48 | 2019 | |
| Pacira Therapeutics, INC. | $14.00 | 2019 | |
| Biodelivery Sciences International, INC. | $13.73 | 2019 | |
| Allergan, INC. | $13.24 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.10 | 2019 | |
| Electronic Waveform Lab, INC. | $8.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giovanni Ramundo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.